4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-113545
Chief Commercial Officer sold 1,038 shares at an average $13.29 ($13,794)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Friedl-Naderer Johanna Chief Commercial Officer | 2025-09-04 | Sale 10b5-1 | −894 | $13.27 | $11,863 | 95,017 | D |
| Friedl-Naderer Johanna Chief Commercial Officer | 2025-09-05 | Sale 10b5-1 | −144 | $13.41 | $1,931 | 94,873 | D |
| Open-market sales · 1,038 sh · avg $13.29 · $13,794 | |||||||
Loading xslF345X05/ownership.xml…